Renaissance Venture Capital

Autobooks, Inc. is a provider of integrated payment and accounting software designed for small businesses and delivered through financial institutions. Founded in 2015 and based in Detroit, Michigan, Autobooks offers a cloud-based platform that simplifies the management of cash flow and automates accounting processes. The platform enables small businesses to easily receive payments online, reconcile accounts, and access tools for invoicing, bill payment, and merchant services. By embedding its services within existing digital banking channels, Autobooks allows financial institutions to enhance their offerings and provide essential back-office support for their small business clients. The company, which was previously known as Automated Booking, Inc., rebranded to Autobooks, Inc. in March 2018.

Strata Oncology, Inc. is a precision oncology company focused on improving cancer care by increasing patient access to clinical trials and expediting drug approvals. The company operates a national precision oncology platform that connects patient screening to streamlined enrollment in mutation-matched clinical trials. Strata collaborates with major healthcare systems to facilitate the genomic sequencing of cancer patients' biopsies in high-throughput laboratories, providing oncologists with timely tumor profiles that inform treatment decisions. Its offerings include The Strata Trial, StrataNGS for targeted DNA and RNA sequencing, and StrataPOINT, which integrates electronic medical records with molecular data to ensure comprehensive testing and follow-up for eligible patients. Strata also manages a portfolio of pharmaceutical-sponsored trials tailored to specific biomarkers and operates the Strata Precision Oncology Network, a collaborative effort among cancer centers to advance precision medicine. Founded in 2015 and headquartered in Ann Arbor, Michigan, Strata was previously known as Strata Oncology Research, Inc. until its name change in May 2016.

Next Coast Ventures is a venture capital firm based in Austin, Texas, established in 2015. It focuses on partnering with bold entrepreneurs to support the development of innovative companies in significant markets, particularly in non-coastal regions. The firm specializes in providing early-stage capital to high-growth startups, with a keen interest in sectors such as workplace solutions, healthcare and wellness, retail, and marketplace software. By leveraging macro trends and themes, Next Coast Ventures aims to guide its investment strategy effectively. The firm enhances its portfolio companies' growth by offering hands-on resources, drawing from a robust industry network and the founders' entrepreneurial experiences.

Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company focuses on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. This next-generation insulin sensitizer aims to address the underlying pathophysiology of NASH, a condition characterized by fat accumulation and inflammation in the liver that can lead to severe complications such as cirrhosis and liver cancer. Cirius Therapeutics is committed to providing innovative solutions to healthcare providers for managing liver and metabolic diseases.

Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on addressing significant unmet medical needs by creating distinct therapies that improve clinical care. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing the quality of life for patients, families, and caregivers.

Atlas Venture is an early-stage venture capital firm based in Cambridge, Massachusetts, founded in 1980. The firm specializes in creating and investing in biotech startup companies, primarily in the life sciences sector, and emphasizes a seed-led venture creation strategy. Atlas Venture focuses on identifying and nurturing promising entrepreneurs to build scalable businesses that can deliver significant value. The firm has a history of successful investments, with a portfolio that includes over 350 companies across various countries, resulting in numerous acquisitions and public offerings. Atlas Venture typically invests between $500,000 and $5 million in its early-stage ventures, and its investment team consists of experienced operating executives and venture capitalists. The firm has established separate teams dedicated to life sciences and technology, with the life sciences group retaining the Atlas name.

ArborMetrix, Inc. is a data analytics and technology company focused on enhancing healthcare outcomes and advancing research through its innovative platform. Founded in 2011 and headquartered in Ann Arbor, Michigan, ArborMetrix offers a range of solutions for the healthcare industry, including data collection and integration, performance measurement, and analytics. Its products, such as EpisodeMetrix, provide critical insights into payer claims data, helping healthcare payers and at-risk providers manage costs and improve specialty care quality. The company also offers RegistryMetrix, which allows for the creation of specialized clinical registries, and SurgicalMetrix, which analyzes the performance of surgical groups by integrating clinical, financial, and operational data. ArborMetrix serves a diverse clientele that includes specialty societies, medical device manufacturers, pharmaceutical companies, and health systems, delivering actionable insights to optimize clinical outcomes and financial performance.

Swift Biosciences, Inc. develops molecular biology reagents for research and diagnostic applications. Swift Biosciences, Inc. is based in Ann Arbor, Michigan.

Fidelis SeniorCare, Inc., a managed care company, develops and administers health plans for assisted living residents in Michigan, North Carolina, and Texas. The company offers Medicare advantage special needs plans to cover the health needs of seniors living in nursing homes and assisted living communities; and individuals who require specialized healthcare. Its plans cover on-site primary care team visits, part D prescription drugs, monitoring and managing prescribed medications, transportation to the hospital or physician’s office, and skilled nursing services during a covered Medicare stay; preventive care, screening, vision/dental/hearing, and podiatry services; and emergency room, ambulance, and urgent care services. The company was founded in 2004 and is based in Schaumburg, Illinois.

RPM Ventures is an early-stage venture capital firm founded in 2000, specializing in investments in high-tech and information technology sectors. With a focus on seed and early-stage companies, RPM Ventures targets businesses that serve the Midwest Fortune 500 manufacturing base or are based on technology developed at leading Midwest research institutions. The firm is recognized for its expertise in various sectors, including FinTech, InsurTech, Real Estate Tech, and has a particular emphasis on Mobility and Transportation. RPM Ventures seeks opportunities in advanced materials processing, data discovery and analytics, manufacturing quality systems, and software automation, among others. Originally established as Waypoint Ventures, the firm rebranded in 2006 to better reflect its strategic focus on leveraging the strengths of the Midwest.

Arboretum Ventures LLC is a venture capital firm based in Ann Arbor, Michigan, founded in 2002. The firm specializes in seed-stage, early-stage, mid-stage investments, and growth capital, primarily focusing on the healthcare sector. Its investment areas include medical devices, diagnostics, healthcare information technology, therapeutics, technology-based healthcare services, and life science tools. Arboretum Ventures aims to invest between $5 million and $15 million in companies across the United States, with a particular emphasis on the Midwest and Michigan. The firm is recognized for its commitment to fostering innovation within the healthcare industry.